Daylife Select
A point & click tool to create dynamic content portals. Learn More »
Pfizer reported higher third-quarter profit as aggressive cost-cutting helped offset unfavorable foreign currency exchange rates and declining sales of drugs, including those facing competition from cheaper generics. Full Article at CNBC